Literature DB >> 19321201

Public disclosure of clinical research.

Ellen Strahlman1, Frank Rockhold, Andrew Freeman.   

Abstract

Mesh：

Year:  2009        PMID： 19321201     DOI： 10.1016/S0140-6736(09)60613-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Are results from pharmaceutical-company-sponsored studies available to the public?

Authors:  Rafael Dal-Ré; Alejandro Pedromingo; Manuel García-Losa; Juan Lahuerta; Rafael Ortega
Journal:  Eur J Clin Pharmacol       Date:  2010-09-16       Impact factor: 2.953

2.  Registration of observational studies: is it time?

Authors:  Rebecca J Williams; Tony Tse; William R Harlan; Deborah A Zarin
Journal:  CMAJ       Date:  2010-07-19       Impact factor: 8.262

3.  Ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research: a joint journal and pharmaceutical industry perspective.

Authors:  Bernadette A Mansi; Juli Clark; Frank S David; Thomas M Gesell; Susan Glasser; John Gonzalez; Daniel G Haller; Christine Laine; Charles L Miller; LaVerne A Mooney; Maja Zecevic
Journal:  Mayo Clin Proc       Date:  2012-05       Impact factor: 7.616

4.  Informed consent: time for more transparency.

Authors:  Yusuf Yazici; Hasan Yazici
Journal:  Arthritis Res Ther       Date:  2010-06-03       Impact factor: 5.156

5.  Modifiers of short-term effects of ozone on mortality in eastern Massachusetts--a case-crossover analysis at individual level.

Authors:  Cizao Ren; Steve Melly; Joel Schwartz
Journal:  Environ Health       Date:  2010-01-21       Impact factor: 5.984
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.